Table 2 Response according to various clinical and pathological parameters
Parameter | Response | % | No response | % | P -value |
---|---|---|---|---|---|
Tumour stage | 0.71 | ||||
T1–2 | 2 | 17 | 10 | 83 | |
T3–4 | 11 | 26 | 31 | 74 | |
Nodal status | 0.004 | ||||
N0 | 9 | 47 | 10 | 53 | |
N1–2 | 3 | 9 | 30 | 91 | |
Treatment | 0.002 | ||||
RT | 4 | 10 | 34 | 90 | |
RCT | 9 | 47 | 10 | 53 | |
TS | 0.20 | ||||
Low | 3 | 14 | 18 | 86 | |
High | 10 | 32 | 21 | 68 | |
P53 | 0.71 | ||||
Negative | 2 | 15 | 11 | 85 | |
Positive | 11 | 26 | 31 | 74 | |
VEGF | 0.31 | ||||
Negative | 7 | 33 | 14 | 67 | |
Positive | 5 | 17 | 24 | 83 | |
P21 | 0.74 | ||||
Negative | 4 | 18 | 18 | 82 | |
Positive | 8 | 25 | 24 | 75 | |
MLH1 | 0.15 | ||||
Preserved | 12 | 29 | 29 | 71 | |
Altered | 1 | 7 | 13 | 93 | |
MSH2 | 0.71 | ||||
Preserved | 11 | 26 | 31 | 74 | |
Altered | 2 | 15 | 11 | 85 |